Human Insulin Market by Drugs & Applications Human Insulin Market by Drugs & Applications | Page 18

LIST OF TABLES • TABLE 1 KEY HUMAN INSULIN DRUGS: YEAR OF PATENT EXPIRY................................................................................38 • TABLE 2 KEY HUMAN INSULIN THERAPIES UNDER PIPELINE DEVELOPMENT & COMMERCIALIZATION: 2005-2015...............................................................................................................50 • TABLE 3 HUMAN INSULIN PIPELINE: MAJOR COMPANIES INVOLVED..........................................................................51 • TABLE 4 HUMAN INSULIN PIPELINE: STAGES OF CLINICAL TRIAL...............................................................................52 • TABLE 5 GLOBAL HUMAN INSULIN MARKET SIZE, BY PRODUCT TYPE, 2013–2020 (USD MILLION)...............................................................................................................................57 • TABLE 6 HUMAN INSULIN DRUGS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)........................................59 • TABLE 7 HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)...............................................................................................................................60 • TABLE 8 GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)...............................................................................................................................62 • TABLE 9 GLOBAL INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)...............................................................................................................................63 • TABLE 10 INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)...................64 • TABLE 11 LONG-ACTING INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)..........................................................................................................65 • TABLE 12 RAPID-ACTING INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)..........................................................................................................66 • TABLE 13 PREMIXED INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)..........................................................................................................67 • TABLE 14 GLOBAL HUMAN INSULIN BIOLOGICS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)........................68 • TABLE 15 HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)..................................69 • TABLE 16 SHORT-ACTING HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)..........................................................................................................70 • TABLE 17 INTERMEDIATE-ACTING HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)..........................................................................................................71 • TABLE 18 PREMIXED HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)...............72 • TABLE 19 GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2013–2020 (USD MILLION).............................................................................................74 • TABLE 20 GLOBAL INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY BRAND, 2013–2020 (USD MILLION)...........................................................................................................75 • TABLE 21 INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)...................76 [email protected] www.marketsandmarkets.com 18